In today’s briefing:
- Aequitas ASEAN IPOs Bookrunner Performance (2019-2022)
- Pre-IPO New Ruipeng Pet Group (RPET.US)- The Industry, the Business and the Concerns
Aequitas ASEAN IPOs Bookrunner Performance (2019-2022)
- In this note, we will take a look at bookrunner performance for ASEAN IPOs from 2019-2022.
- The following dataset includes all ASEAN IPOs above US$100m for the period of Calendar Years 2019-2022, which amounted to a total of 41 deals.
- The deals you see in this note are based on our historical IPO tracker. Feel free to drop us a message for additional information on any of these IPOs.
Pre-IPO New Ruipeng Pet Group (RPET.US)- The Industry, the Business and the Concerns
- Pet medical industry is the second largest core industry after pet food industry.Pet hospital,with dual attributes of medical treatment and consumption,represents the direction of consumption upgrading and has huge potential.
- New Ruipeng maintained rapid growth these years, but its business is still in the investment period. The Company is hard to generate high profit/returns due to low gross margin level.
- There’re still technical bottlenecks in China.If New Ruipeng can fill these market gaps in time and provide comprehensive pet medical solutions, its development space and moat will be much higher.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
